Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 



